Related references
Note: Only part of the references are listed.Drugs targeting 5-hydroxytryptamine receptors in acute treatments of migraine attacks. A review of new drugs and new administration forms of established drugs
Peer C. Tfelt-Hansen et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
Dural neurogenic inflammation induced by neuropathic pain is specific to cranial region
B. Filipovic et al.
JOURNAL OF NEURAL TRANSMISSION (2014)
Pre-treatment with new kynurenic acid amide dose-dependently prevents the nitroglycerine-induced neuronal activation and sensitization in cervical part of trigemino-cervical complex
Annamaria Fejes-Szabo et al.
JOURNAL OF NEURAL TRANSMISSION (2014)
CGRP as a new target in prevention and treatment of migraine Comment
Hans-Christoph Diener
LANCET NEUROLOGY (2014)
Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice
Francesco Fazio et al.
NEUROPHARMACOLOGY (2014)
GLUTAMATE DYSREGULATION IN THE TRIGEMINAL GANGLION: A NOVEL MECHANISM FOR PERIPHERAL SENSITIZATION OF THE CRANIOFACIAL REGION
J. C. Laursen et al.
NEUROSCIENCE (2014)
Identification of Cinnabarinic Acid as a Novel Endogenous Aryl Hydrocarbon Receptor Ligand That Drives IL-22 Production
Margaret M. Lowe et al.
PLOS ONE (2014)
Pharmacogenetic insights into migraine treatment in children
Giovanna Gentile et al.
PHARMACOGENOMICS (2014)
Kynurenic acid as an antagonist of α7 nicotinic acetylcholine receptors in the brain: Facts and challenges
Edson X. Albuquerque et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Migraine generator network and spreading depression dynamics as neuromodulation targets in episodic migraine
Markus A. Dahlem
CHAOS (2013)
Increased 3-Hydroxykynurenine serum concentrations differentiate Alzheimer's disease patients from controls
Markus J. Schwarz et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2013)
Cortical spreading depression as a target for anti-migraine agents
Cinzia Costa et al.
JOURNAL OF HEADACHE AND PAIN (2013)
Headache and mechanical sensitization of human pericranial muscles after repeated intake of monosodium glutamate (MSG)
Akiko Shimada et al.
JOURNAL OF HEADACHE AND PAIN (2013)
Kynurenines in the CNS: recent advances and new questions
Laszlo Vecsei et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Cortical spreading depression and migraine
Andrew C. Charles et al.
NATURE REVIEWS NEUROLOGY (2013)
Evaluation of c-Fos immunoreactivity in the rat brainstem nuclei relevant in migraine pathogenesis after electrical stimulation of the trigeminal ganglion
Zsuzsanna Bohar et al.
NEUROLOGICAL SCIENCES (2013)
Actions of Xanthurenic Acid, a putative endogenous Group II metabotropic glutamate receptor agonist, on sensory transmission in the thalamus
C. S. Copeland et al.
NEUROPHARMACOLOGY (2013)
Migraine pathophysiology: Anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain
Rodrigo Noseda et al.
PAIN (2013)
Kynurenic acid inhibits glutamatergic transmission to CA1 pyramidal neurons via α7 nAChR-dependent and -independent mechanisms
Jyotirmoy Banerjee et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Effect of systemic kynurenine on cortical spreading depression and its modulation by sex hormones in rat
Virginie Chauvel et al.
EXPERIMENTAL NEUROLOGY (2012)
Kynurenines and headache
Arpad Pardutz et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery
Flavio Moroni et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Where does a migraine attack originate? In the brainstem
J. Tajti et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Kynurenines in the mammalian brain: when physiology meets pathology
Robert Schwarcz et al.
NATURE REVIEWS NEUROSCIENCE (2012)
Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
F. Fazio et al.
MOLECULAR PHARMACOLOGY (2012)
Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naive and medication-free schizophrenic patients
A. M. Myint et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Kynurenine Metabolites and Migraine: Experimental Studies and Therapeutic Perspectives
Annamaria Fejes et al.
CURRENT NEUROPHARMACOLOGY (2011)
Treatment of migraine: update on new therapies
Delphine Magis et al.
CURRENT OPINION IN NEUROLOGY (2011)
On the antioxidant properties of kynurenic acid: Free radical scavenging activity and inhibition of oxidative stress
R. Lugo-Huitron et al.
NEUROTOXICOLOGY AND TERATOLOGY (2011)
Kynurenate Derivative Attenuates the Nitroglycerin-Induced CamKIIα and CGRP Expression Changes
Eniko Vamos et al.
HEADACHE (2010)
Kynurenine is an endothelium-derived relaxing factor produced during inflammation
Yutang Wang et al.
NATURE MEDICINE (2010)
The Peripheral Antinociceptive Effects of Endomorphin-1 and Kynurenic Acid in the Rat Inflamed Joint Model
Laszlo Mecs et al.
ANESTHESIA AND ANALGESIA (2009)
Urodynamics post stroke in patients with urinary incontinence: Is there correlation between bladder type and site of lesion
Anupam Gupta et al.
ANNALS OF INDIAN ACADEMY OF NEUROLOGY (2009)
L-kynurenine combined with probenecid and the novel synthetic kynurenic acid derivative attenuate nitroglycerin-induced nNOS in the rat caudal trigeminal nucleus
Eniko Vamos et al.
NEUROPHARMACOLOGY (2009)
Xanthurenic acid distribution, transport, accumulation and release in the rat brain
Serge Gobaille et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder
Christine L. Miller et al.
NEUROCHEMISTRY INTERNATIONAL (2008)
A comparative study of excitatory and inhibitory amino acids in three different brainstem nuclei
Waleed M. Renno et al.
NEUROCHEMICAL RESEARCH (2008)
The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection
Corrado Corti et al.
JOURNAL OF NEUROSCIENCE (2007)
Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain
Paolo Guidetti et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Kynurenine in combination with probenecid mitigates the stimulation-induced increase of c-fos immunoreactivity of the rat caudal trigeminal nucleus in an experimental migraine model
E. Knyihar-Csillik et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
The global burden of headache: a documentation of headache prevalence and disability worldwide
L. J. Stovner et al.
CEPHALALGIA (2007)
Tryptophan depletion increases nausea, headache and photophobia in migraine sufferers
P. D. Drummond
CEPHALALGIA (2006)
Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35
Jinghong Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Neurochemistry of trigeminal activation in an animal model of migraine
ML Oshinsky et al.
HEADACHE (2006)
Cortical spreading depression confounds concentration-dependent pial arteriolar dilation during N-methyl-D-aspartate superfusion
C Ayata et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism
O Takikawa
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Kynurenine aminotransferase in the supratentorial dura mater of the rat:: effect of stimulation of the trigeminal ganglion
E Knyihár-Csillik et al.
EXPERIMENTAL NEUROLOGY (2004)
Cortical spreading depression augments kynurenate levels and reduces malonate toxicity in the rat cortex
C Kiss et al.
BRAIN RESEARCH (2004)
Interferon-γ-induced conversion of tryptophan:: Immunologic and neuropsychiatric aspects
B Wirleitner et al.
CURRENT MEDICINAL CHEMISTRY (2003)
Kynurenic acid enhances electroacupuncture analgesia in normal and carrageenan-injected rats
YQ Zhang et al.
BRAIN RESEARCH (2003)
Manipulation of brain kynurenines: Glial targets, neuronal effects, and clinical opportunities
R Schwarcz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
T cell apoptosis by tryptophan catabolism
I Fallarino et al.
CELL DEATH AND DIFFERENTIATION (2002)
Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes
RG Tavares et al.
NEUROCHEMISTRY INTERNATIONAL (2002)
Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model
H Bolay et al.
NATURE MEDICINE (2002)
Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages
A Chiarugi et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Immunological aspects in migraine: Increase of IL-10 plasma levels during attack
I Munno et al.
HEADACHE (2001)
Periaqueductal gray matter dysfunction in migraine: Cause or the burden of illness?
KMA Welch et al.
HEADACHE (2001)
3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote α-crystallin cross-linking by metal ion reduction
LE Goldstein et al.
BIOCHEMISTRY (2000)
Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection
TW Stone
TRENDS IN PHARMACOLOGICAL SCIENCES (2000)
Share Paper
